Other
Opioids
0
Pipeline Programs↗
7
Active Trials↗
1
Companies Involved↗
Opioids is an early-stage landscape with 0 programs across 1 company. The most active players are Shionogi.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
23
clinical trials
Completed9 · 39%
Terminated5 · 22%
Recruiting4 · 17%
Not yet recruiting2 · 9%
Enrolling by invitation1 · 4%
Unknown status1 · 4%
Other1 · 4%
Clinical Trials
Trial Activity
23 trials
Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
Recruiting·—·Phase 1·NCT05610072·24 enrolled
Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences
Recruiting·—·Phase 1·NCT05007561·210 enrolled
Impacts of Opioids on Respiratory Drive During Sleep
Not yet recruiting·—·Phase 1·NCT06854211·26 enrolled
Reducing the Abuse Liability of Prescription Opioids
Completed·TThe University of Texas Health Science Center at San Antonio·Phase 1·NCT04587115·15 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)